Back to SYRE

SILVERARC CAPITAL MANAGEMENT, LLC → SYRE

SILVERARC CAPITAL MANAGEMENT, LLC SYRE Position History

Spyre Therapeutics, Inc. • Healthcare

Quarters held
4
Latest value
$13.5M
Q3 2026
Peak value
$13.5M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$6.2M
Q1 2026$9.4M
Q2 2026$5.3M
Q3 2026$13.5M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$13.5M151.2K——
Q2 2026$5.3M60.0K——
Q1 2026$9.4M186.6K——
Q4 2025$6.2M187.7K——

Other funds holding SYRE

Other SILVERARC CAPITAL MANAGEMENT, LLC positions

KOD

KODIAK SCIENCES INC

$71.1M
CELC

CELCUITY INC

$63.9M
KALU

KALVISTA PHARMACEUTICALS INC

$57.9M
AAVXF

ABIVAX SA

$56.9M
ASND

ASCENDIS PHARMA A/S

$55M
DNTH

DIANTHUS THERAPEUTICS INC

$54.9M
CELC

CELCUITY INC

$52.4M
COGT

COGENT BIOSCIENCES INC

$50.6M